Since cross‐reactive IgA against the SARS‐CoV‐2S1 subunit42 and cationic proteins43 in saliva may also exert inhibitory effects, these proteins need to be considered as a valuable strategy to prevent SARS‐CoV‐2 infection and the spread of COVID‐19. This evidence concerns the gene CD79A and COVID-19.